Skip to main content

Advertisement

SpringerLink
Log in

Vaping and Cardiovascular Health: the Case for Health Policy Action

  • Cardiovascular Risk Health Policy (W. Rosamond,Section Editor)
  • Published:
Current Cardiovascular Risk Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

E-cigarette smoking is rapidly increasing, especially in adolescents and adults, although data on their safety or harm is still scarce. There have been few systematic studies of the health effects of e-cigarette use and most studies report on the use of e-cigarettes in past or current cigarette smokers. In this paper, we want to summarize cardiovascular effects of e-cigarettes.

Recent Findings

E-cigarettes could cause cardiovascular harm especially by the toxic effects and of the e-liquid and induction of oxidative stress. Nicotine has known effects on cardiovascular function that are not different in e-cigarettes to those in combustible cigarettes. Moreover, vaping nicotine could be the driver for future revival of combustible smoking.

Summary

Although it seems that e-cigarettes are a safer alternative than combustible cigarettes for people that want to stop smoking, toxic effects of the e-liquid can induce an increase in cardiovascular risk. Long-term data of their safety are still scarce or even lacking and most data are generated in studies with active or past regular cigarette smokers. More data on the cardiovascular and metabolic side effects of vaping are warranted in people naïve for smoking combustible cigarettes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. National Academies of Sciences E, Medicine, Health, Medicine D, Board on Population H, Public Health P et al. In: Eaton DL, Kwan LY, Stratton K, editors. Public Health Consequences of E-Cigarettes. Washington (DC): National Academies Press (US) Copyright 2018 by the National Academy of Sciences. All rights reserved.; 2018.

  2. Bals R, Boyd J, Esposito S, Foronjy R, Hiemstra PS, Jimenez-Ruiz CA, et al. Electronic cigarettes—Task Force report from the European Respiratory Society. Eur Respir J. 2018. https://doi.org/10.1183/13993003.01151-2018.

    Article  CAS  Google Scholar 

  3. Johnston LD MR, O’Malley PM, Bachman JG, Schulenberg JE, Patrick ME. Monitoring the future national survey results on drug use: 1975-2017: Overview, key findings on adolescent drug use. Ann Arbor2018.

  4. Menakuru S, Inzamam AM. Beliefs and reality of e-cigarette smoking. BMJ Case Rep. 2018;2018. https://doi.org/10.1136/bcr-2018-225683.

  5. Whittington JR, Simmons PM, Phillips AM, Gammill SK, Cen R, Magann EF, et al. The use of electronic cigarettes in pregnancy: a review of the literature. Obstetrical Gynecol Survey. 2018;73(9):544–9. https://doi.org/10.1097/ogx.0000000000000595.

    Article  Google Scholar 

  6. Berry KM, Fetterman JL, Benjamin EJ, Bhatnagar A, Barrington-Trimis JL, Leventhal AM, et al. Association of electronic cigarette use with subsequent initiation of tobacco cigarettes in US youths. JAMA Netw Open. 2019;2(2):e187794. https://doi.org/10.1001/jamanetworkopen.2018.7794.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Ambrose BK, Day HR, Rostron B, Conway KP, Borek N, Hyland A, et al. Flavored tobacco product use among US youth aged 12-17 years, 2013-2014. Jama. 2015;314(17):1871–3. https://doi.org/10.1001/jama.2015.13802.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Corey CG, Ambrose BK, Apelberg BJ, King BA. Flavored tobacco product use among middle and high school students—United States, 2014. MMWR Morb Mortal Wkly Rep. 2015;64(38):1066–70. https://doi.org/10.15585/mmwr.mm6438a2.

    Article  PubMed  Google Scholar 

  9. FDA. Family Smoking Prevention And Tobacco Control Act, Pub. L. No. 111–131, H.R. 1256 (June 22, 2009). . 2009. http://www.fda.gov/TobaccoProducts/Labeling/RulesRegulationsGuidance/ucm246129.htm. Accessed august 24 2019.

  10. FDA. U.S. Food and Drug Administration. FDA’s new regulations for e-cigarettes, cigars, and all other tobacco products. 2016. U.S. Food and Drug Administration. FDA’s New Regulations for E-Cigarettes, Cigars, and All Other Tobacco Products. Accessed August 24 2019.

  11. Drazen JM, Morrissey S, Campion EW. The dangerous flavors of e-cigarettes. N Engl J Med. 2019. https://doi.org/10.1056/NEJMe1900484.

    Article  Google Scholar 

  12. Soneji S, Barrington-Trimis JL, Wills TA, Leventhal AM, Unger JB, Gibson LA, et al. Association between initial use of e-cigarettes and subsequent cigarette smoking among adolescents and young adults: a systematic review and meta-analysis. JAMA Pediatr. 2017;171(8):788–97. https://doi.org/10.1001/jamapediatrics.2017.1488.

    Article  PubMed  PubMed Central  Google Scholar 

  13. FDA. Statement from FDA Commissioner Scott Gottlieb, M.D., on advancing new policies aimed at preventing youth access to, and appeal of, flavored tobacco products, including e-cigarettes and cigars. 2019, march 13. https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm633291.htm.

  14. Liu X, Lu W, Liao S, Deng Z, Zhang Z, Liu Y, et al. Efficiency and adverse events of electronic cigarettes: a systematic review and meta-analysis (PRISMA-compliant article). Medicine. 2018;97(19):e0324. https://doi.org/10.1097/md.0000000000010324.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Hajek P, Phillips-Waller A, Przulj D, Pesola F, Myers Smith K, Bisal N, et al. A randomized trial of e-cigarettes versus nicotine-replacement therapy. N Engl J Med. 2019. https://doi.org/10.1056/NEJMoa1808779.

    Article  Google Scholar 

  16. Kalkhoran S, Glantz SA. E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and meta-analysis. Lancet Respir Med. 2016;4(2):116–28. https://doi.org/10.1016/s2213-2600(15)00521-4.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Britton J, Arnott D, McNeill A, Hopkinson N. Nicotine without smoke-putting electronic cigarettes in context. BMJ (Clinical research ed). 2016;353:i1745. https://doi.org/10.1136/bmj.i1745.

    Article  Google Scholar 

  18. Choi K, Bestrashniy J, Forster J. Trends in awareness, use of, and beliefs about electronic cigarette and snus among a longitudinal cohort of US Midwest young adults. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco. 2018;20(2):239–45. https://doi.org/10.1093/ntr/ntx042.

    Article  Google Scholar 

  19. Gentzke AS, Creamer M, Cullen KA, Ambrose BK, Willis G, Jamal A, et al. Vital signs: tobacco product use among middle and high school students—United States, 2011-2018. MMWR Morbidity and mortality weekly report. 2019;68(6):157–64. https://doi.org/10.15585/mmwr.mm6806e1.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Chaffee BW, Watkins SL, Glantz SA. Electronic cigarette use and progression from experimentation to established smoking. Pediatrics. 2018;141(4). https://doi.org/10.1542/peds.2017-3594.

    Article  Google Scholar 

  21. Soneji SS, Knutzen KE, Villanti AC. Use of flavored e-cigarettes among adolescents, young adults, and older adults: findings from the population assessment for tobacco and health study. Public health reports (Washington, DC : 1974). 2019:33354919830967. https://doi.org/10.1177/0033354919830967.

    Article  Google Scholar 

  22. Schneller LM, Bansal-Travers M, Goniewicz ML, McIntosh S, Ossip D, O'Connor RJ. Use of flavored electronic cigarette refill liquids among adults and youth in the US-Results from Wave 2 of the Population Assessment of Tobacco and Health Study (2014-2015). PloS one. 2018;13(8):e0202744. https://doi.org/10.1371/journal.pone.0202744.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Audrain-McGovern J, Strasser AA, Wileyto EP. The impact of flavoring on the rewarding and reinforcing value of e-cigarettes with nicotine among young adult smokers. Drug Alcohol Depend. 2016;166:263–7. https://doi.org/10.1016/j.drugalcdep.2016.06.030.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Huang J, Duan Z, Kwok J, Binns S, Vera LE, Kim Y, et al. Vaping versus JUULing: how the extraordinary growth and marketing of JUUL transformed the US retail e-cigarette market. Tob Control. 2019;28(2):146–51. https://doi.org/10.1136/tobaccocontrol-2018-054382.

    Article  PubMed  Google Scholar 

  25. Kamerow D. Popular e-cigarette Juul comes under attack. BMJ (Clinical research ed). 2019;365:l4249. https://doi.org/10.1136/bmj.l4249.

    Article  Google Scholar 

  26. McMillen RC, Gottlieb MA, Shaefer RM, Winickoff JP, Klein JD. Trends in electronic cigarette use among U.S. adults: use is increasing in both smokers and nonsmokers. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco. 2015;17(10):1195–202. https://doi.org/10.1093/ntr/ntu213.

    Article  Google Scholar 

  27. Pepper JK, Ribisl KM, Emery SL, Brewer NT. Reasons for starting and stopping electronic cigarette use. Int J Environ Res Public Health. 2014;11(10):10345–61. https://doi.org/10.3390/ijerph111010345.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Polosa R, Cibella F, Caponnetto P, Maglia M, Prosperini U, Russo C, et al. Health impact of E-cigarettes: a prospective 3.5-year study of regular daily users who have never smoked. Sci Rep. 2017;7(1):13825. https://doi.org/10.1038/s41598-017-14043-2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Farsalinos K, Cibella F, Caponnetto P, Campagna D, Morjaria JB, Battaglia E, et al. Effect of continuous smoking reduction and abstinence on blood pressure and heart rate in smokers switching to electronic cigarettes. Intern Emerg Med. 2016;11(1):85–94. https://doi.org/10.1007/s11739-015-1361-y.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Polosa R, Morjaria JB, Caponnetto P, Battaglia E, Russo C, Ciampi C, et al. Blood pressure control in smokers with arterial hypertension who switched to electronic cigarettes. International journal of environmental research and public health. 2016;13(11). https://doi.org/10.3390/ijerph13111123.

    Article  Google Scholar 

  31. Kleiger RE, Miller JP, Bigger JT Jr, Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol. 1987;59(4):256–62.

    Article  CAS  Google Scholar 

  32. Hillebrand S, Gast KB, de Mutsert R, Swenne CA, Jukema JW, Middeldorp S, et al. Heart rate variability and first cardiovascular event in populations without known cardiovascular disease: meta-analysis and dose-response meta-regression. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2013;15(5):742–9. https://doi.org/10.1093/europace/eus341.

    Article  Google Scholar 

  33. Moheimani RS, Bhetraratana M, Yin F, Peters KM, Gornbein J, Araujo JA, et al. Increased cardiac sympathetic activity and oxidative stress in habitual electronic cigarette users: implications for cardiovascular risk. JAMA Cardiol. 2017;2(3):278–84. https://doi.org/10.1001/jamacardio.2016.5303.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Osei AD, Mirbolouk M, Orimoloye OA, Dzaye O, Uddin SMI, Benjamin EJ, et al. The association between e-cigarette use and cardiovascular disease among never and current combustible cigarette smokers: BRFSS 2016 & 2017. Am J Med. 2019. https://doi.org/10.1016/j.amjmed.2019.02.016.

    Article  Google Scholar 

  35. Alzahrani T, Pena I, Temesgen N, Glantz SA. Association between electronic cigarette use and myocardial infarction. Am J Prev Med. 2018;55(4):455–61. https://doi.org/10.1016/j.amepre.2018.05.004.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Csordas A, Bernhard D. The biology behind the atherothrombotic effects of cigarette smoke. Nat Rev Cardiol. 2013;10(4):219–30. https://doi.org/10.1038/nrcardio.2013.8.

    Article  CAS  PubMed  Google Scholar 

  37. Henningfield JE, Keenan RM. Nicotine delivery kinetics and abuse liability. J Consult Clin Psychol. 1993;61(5):743–50. https://doi.org/10.1037//0022-006x.61.5.743.

    Article  CAS  PubMed  Google Scholar 

  38. DeVito EE, Krishnan-Sarin S. E-cigarettes: impact of e-liquid components and device characteristics on nicotine exposure. Curr Neuropharmacol. 2018;16(4):438–59. https://doi.org/10.2174/1570159x15666171016164430.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Nardone N, Helen GS, Addo N, Meighan S, Benowitz NL. JUUL electronic cigarettes: nicotine exposure and the user experience. Drug Alcohol Depend. 2019;203:83–7. https://doi.org/10.1016/j.drugalcdep.2019.05.019.

    Article  CAS  PubMed  Google Scholar 

  40. Benowitz NL, Burbank AD. Cardiovascular toxicity of nicotine: Implications for electronic cigarette use. Trends in cardiovascular medicine. 2016;26(6):515–23. https://doi.org/10.1016/j.tcm.2016.03.001.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Benowitz NL, Fraiman JB. Cardiovascular effects of electronic cigarettes. Nat Rev Cardiol. 2017;14(8):447–56. https://doi.org/10.1038/nrcardio.2017.36.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Konishi H, Wu J, Cooke JP. Chronic exposure to nicotine impairs cholinergic angiogenesis. Vascular medicine (London, England). 2010;15(1):47–54. https://doi.org/10.1177/1358863x09106326.

    Article  Google Scholar 

  43. Mills EJ, Thorlund K, Eapen S, Wu P, Prochaska JJ. Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis. Circulation. 2014;129(1):28–41. https://doi.org/10.1161/circulationaha.113.003961.

    Article  CAS  PubMed  Google Scholar 

  44. Joseph AM, Norman SM, Ferry LH, Prochazka AV, Westman EC, Steele BG, et al. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med. 1996;335(24):1792–8. https://doi.org/10.1056/nejm199612123352402.

    Article  CAS  PubMed  Google Scholar 

  45. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;55(13):1318–27. https://doi.org/10.1016/j.jacc.2009.10.061.

    Article  PubMed  Google Scholar 

  46. Haass M, Kubler W. Nicotine and sympathetic neurotransmission. Cardiovasc Drugs Ther. 1997;10(6):657–65.

    Article  CAS  Google Scholar 

  47. Piano MR, Benowitz NL, Fitzgerald GA, Corbridge S, Heath J, Hahn E, et al. Impact of smokeless tobacco products on cardiovascular disease: implications for policy, prevention, and treatment: a policy statement from the American Heart Association. Circulation. 2010;122(15):1520–44. https://doi.org/10.1161/CIR.0b013e3181f432c3.

    Article  PubMed  Google Scholar 

  48. Oakes JM, Fuchs RM, Gardner JD, Lazartigues E, Yue X. Nicotine and the renin-angiotensin system. Am J Physiol Regul Integr Comp Physiol. 2018;315(5):R895–r906. https://doi.org/10.1152/ajpregu.00099.2018.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Franzen KF, Willig J, Cayo Talavera S, Meusel M, Sayk F, Reppel M, et al. E-cigarettes and cigarettes worsen peripheral and central hemodynamics as well as arterial stiffness: a randomized, double-blinded pilot study. Vascular medicine (London, England). 2018;23(5):419–25. https://doi.org/10.1177/1358863x18779694.

    Article  Google Scholar 

  50. Chaumont M, de Becker B, Zaher W, Culie A, Deprez G, Melot C, et al. Differential effects of e-cigarette on microvascular endothelial function, arterial stiffness and oxidative stress: a randomized crossover trial. Sci Rep. 2018;8(1):10378. https://doi.org/10.1038/s41598-018-28723-0.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Vlachopoulos C, Ioakeimidis N, Abdelrasoul M, Terentes-Printzios D, Georgakopoulos C, Pietri P, et al. Electronic cigarette smoking increases aortic stiffness and blood pressure in young smokers. J Am Coll Cardiol. 2016;67(23):2802–3. https://doi.org/10.1016/j.jacc.2016.03.569.

    Article  PubMed  Google Scholar 

  52. Meine TJ, Patel MR, Washam JB, Pappas PA, Jollis JG. Safety and effectiveness of transdermal nicotine patch in smokers admitted with acute coronary syndromes. Am J Cardiol. 2005;95(8):976–8. https://doi.org/10.1016/j.amjcard.2004.12.039.

    Article  CAS  PubMed  Google Scholar 

  53. Hergens MP, Galanti R, Hansson J, Fredlund P, Ahlbom A, Alfredsson L, et al. Use of Scandinavian moist smokeless tobacco (snus) and the risk of atrial fibrillation. Epidemiology (Cambridge, Mass). 2014;25(6):872–6. https://doi.org/10.1097/ede.0000000000000169.

    Article  Google Scholar 

  54. Hansson J, Galanti MR, Hergens MP, Fredlund P, Ahlbom A, Alfredsson L, et al. Use of snus and acute myocardial infarction: pooled analysis of eight prospective observational studies. Eur J Epidemiol. 2012;27(10):771–9. https://doi.org/10.1007/s10654-012-9704-8.

    Article  PubMed  Google Scholar 

  55. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet (London, England). 2004;364(9438):937–52. https://doi.org/10.1016/s0140-6736(04)17018-9.

    Article  Google Scholar 

  56. Arefalk G, Hambraeus K, Lind L, Michaelsson K, Lindahl B, Sundstrom J. Discontinuation of smokeless tobacco and mortality risk after myocardial infarction. Circulation. 2014;130(4):325–32. https://doi.org/10.1161/circulationaha.113.007252.

    Article  PubMed  Google Scholar 

  57. Yatsuya H, Folsom AR. Risk of incident cardiovascular disease among users of smokeless tobacco in the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol. 2010;172(5):600–5. https://doi.org/10.1093/aje/kwq191.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Jensen K, Nizamutdinov D, Guerrier M, Afroze S, Dostal D, Glaser S. General mechanisms of nicotine-induced fibrogenesis. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2012;26(12):4778–87. https://doi.org/10.1096/fj.12-206458.

    Article  CAS  Google Scholar 

  59. Arefalk G, Hergens MP, Ingelsson E, Arnlov J, Michaelsson K, Lind L, et al. Smokeless tobacco (snus) and risk of heart failure: results from two Swedish cohorts. Eur J Prev Cardiol. 2012;19(5):1120–7. https://doi.org/10.1177/1741826711420003.

    Article  PubMed  Google Scholar 

  60. Messner B, Bernhard D. Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis. Arterioscler Thromb Vasc Biol. 2014;34(3):509–15. https://doi.org/10.1161/atvbaha.113.300156.

    Article  CAS  PubMed  Google Scholar 

  61. King CC, Piper ME, Gepner AD, Fiore MC, Baker TB, Stein JH. Longitudinal impact of smoking and smoking cessation on inflammatory markers of cardiovascular disease risk. Arterioscler Thromb Vasc Biol. 2017;37(2):374–9. https://doi.org/10.1161/atvbaha.116.308728.

    Article  CAS  PubMed  Google Scholar 

  62. Dinakar C, O'Connor GT. The health effects of electronic cigarettes. N Engl J Med. 2016;375(14):1372–81. https://doi.org/10.1056/NEJMra1502466.

    Article  PubMed  Google Scholar 

  63. Zhang G, Wang Z, Zhang K, Hou R, Xing C, Yu Q, et al. Safety assessment of electronic cigarettes and their relationship with cardiovascular disease. International journal of environmental research and public health. 2018;15(1). https://doi.org/10.3390/ijerph15010075.

    Article  Google Scholar 

  64. Geiss O, Bianchi I, Barrero-Moreno J. Correlation of volatile carbonyl yields emitted by e-cigarettes with the temperature of the heating coil and the perceived sensorial quality of the generated vapours. Int J Hyg Environ Health. 2016;219(3):268–77. https://doi.org/10.1016/j.ijheh.2016.01.004.

    Article  CAS  PubMed  Google Scholar 

  65. Brook RD, Rajagopalan S, Pope CA 3rd, Brook JR, Bhatnagar A, Diez-Roux AV, et al. Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association. Circulation. 2010;121(21):2331–78. https://doi.org/10.1161/CIR.0b013e3181dbece1.

    Article  CAS  PubMed  Google Scholar 

  66. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet (London, England). 2017;390(10100):1345-422. https://doi.org/10.1016/s0140-6736(17)32366-8.

    Article  Google Scholar 

  67. Volesky KD, Maki A, Scherf C, Watson L, Van Ryswyk K, Fraser B, et al. The influence of three e-cigarette models on indoor fine and ultrafine particulate matter concentrations under real-world conditions. Environmental pollution (Barking, Essex : 1987). 2018;243(Pt B):882–9. https://doi.org/10.1016/j.envpol.2018.08.069.

    Article  CAS  Google Scholar 

  68. Moris D, Spartalis M, Spartalis E, Karachaliou GS, Karaolanis GI, Tsourouflis G, et al. The role of reactive oxygen species in the pathophysiology of cardiovascular diseases and the clinical significance of myocardial redox. Annals of translational medicine. 2017;5(16):326. https://doi.org/10.21037/atm.2017.06.27.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Golbidi S, Edvinsson L, Laher I. Smoking and endothelial dysfunction. Curr Vasc Pharmacol. 2018. https://doi.org/10.2174/1573403x14666180913120015.

  70. Incalza MA, D'Oria R, Natalicchio A, Perrini S, Laviola L, Giorgino F. Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases. Vasc Pharmacol. 2018;100:1–19. https://doi.org/10.1016/j.vph.2017.05.005.

    Article  CAS  Google Scholar 

  71. Goel R, Durand E, Trushin N, Prokopczyk B, Foulds J, Elias RJ, et al. Highly reactive free radicals in electronic cigarette aerosols. Chem Res Toxicol. 2015;28(9):1675–7. https://doi.org/10.1021/acs.chemrestox.5b00220.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Carnevale R, Sciarretta S, Violi F, Nocella C, Loffredo L, Perri L, et al. Acute impact of tobacco vs electronic cigarette smoking on oxidative stress and vascular function. Chest. 2016;150(3):606–12. https://doi.org/10.1016/j.chest.2016.04.012.

    Article  PubMed  Google Scholar 

  73. Rajagopalan S, Al-Kindi SG, Brook RD. Air pollution and cardiovascular disease: JACC State-of-the-Art Review. J Am Coll Cardiol. 2018;72(17):2054–70. https://doi.org/10.1016/j.jacc.2018.07.099.

    Article  CAS  PubMed  Google Scholar 

  74. Haddad C, Salman R, El-Hellani A, Talih S, Shihadeh A, Saliba NA. Reactive oxygen species emissions from supra- and sub-ohm electronic cigarettes. J Anal Toxicol. 2019;43(1):45–50. https://doi.org/10.1093/jat/bky065.

    Article  PubMed  Google Scholar 

  75. Farsalinos KE, Romagna G, Allifranchini E, Ripamonti E, Bocchietto E, Todeschi S, et al. Comparison of the cytotoxic potential of cigarette smoke and electronic cigarette vapour extract on cultured myocardial cells. Int J Environ Res Public Health. 2013;10(10):5146–62. https://doi.org/10.3390/ijerph10105146.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  76. Olfert IM, DeVallance E, Hoskinson H, Branyan KW, Clayton S, Pitzer CR, et al. Chronic exposure to electronic cigarettes results in impaired cardiovascular function in mice. Journal of applied physiology (Bethesda, Md : 1985). 2018;124(3):573–82. https://doi.org/10.1152/japplphysiol.00713.2017.

    Article  CAS  Google Scholar 

  77. Crotty Alexander LE, Drummond CA, Hepokoski M, Mathew D, Moshensky A, Willeford A, et al. Chronic inhalation of e-cigarette vapor containing nicotine disrupts airway barrier function and induces systemic inflammation and multiorgan fibrosis in mice. Am J Physiol Regul Integr Comp Physiol. 2018;314(6):R834–r47. https://doi.org/10.1152/ajpregu.00270.2017.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Muthumalage T, Prinz M, Ansah KO, Gerloff J, Sundar IK, Rahman I. Inflammatory and oxidative responses induced by exposure to commonly used e-cigarette flavoring chemicals and flavored e-liquids without nicotine. Front Physiol. 2017;8:1130. https://doi.org/10.3389/fphys.2017.01130.

    Article  PubMed  Google Scholar 

  79. Hom S, Chen L, Wang T, Ghebrehiwet B, Yin W, Rubenstein DA. Platelet activation, adhesion, inflammation, and aggregation potential are altered in the presence of electronic cigarette extracts of variable nicotine concentrations. Platelets. 2016;27(7):694–702. https://doi.org/10.3109/09537104.2016.1158403.

    Article  CAS  PubMed  Google Scholar 

  80. Qasim H, Karim ZA, Silva-Espinoza JC, Khasawneh FT, Rivera JO, Ellis CC, et al. Short-term e-cigarette exposure increases the risk of thrombogenesis and enhances platelet function in mice. Journal of the American Heart Association. 2018;7(15). https://doi.org/10.1161/jaha.118.009264.

  81. Sifat AE, Vaidya B, Kaisar MA, Cucullo L, Abbruscato TJ. Nicotine and electronic cigarette (E-Cig) exposure decreases brain glucose utilization in ischemic stroke. J Neurochem. 2018;147(2):204–21. https://doi.org/10.1111/jnc.14561.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  82. Goniewicz ML, Smith DM, Edwards KC, Blount BC, Caldwell KL, Feng J, et al. Comparison of nicotine and toxicant exposure in users of electronic cigarettes and combustible cigarettes. JAMA Netw Open. 2018;1(8):e185937. https://doi.org/10.1001/jamanetworkopen.2018.5937.

    Article  PubMed  PubMed Central  Google Scholar 

  83. Antoniewicz L, Bosson JA, Kuhl J, Abdel-Halim SM, Kiessling A, Mobarrez F, et al. Electronic cigarettes increase endothelial progenitor cells in the blood of healthy volunteers. Atherosclerosis. 2016;255:179–85. https://doi.org/10.1016/j.atherosclerosis.2016.09.064.

    Article  CAS  PubMed  Google Scholar 

  84. Boas Z, Gupta P, Moheimani RS, Bhetraratana M, Yin F, Peters KM, et al. Activation of the “Splenocardiac Axis” by electronic and tobacco cigarettes in otherwise healthy young adults. Physiological reports. 2017;5(17). https://doi.org/10.14814/phy2.13393.

    Article  Google Scholar 

  85. Farley AC, Hajek P, Lycett D, Aveyard P. Interventions for preventing weight gain after smoking cessation. The Cochrane database of systematic reviews. 2012;1:Cd006219. https://doi.org/10.1002/14651858.CD006219.pub3.

    Article  PubMed  Google Scholar 

  86. Bennett BL, Pokhrel P. Weight concerns and use of cigarettes and e-cigarettes among young adults. International journal of environmental research and public health. 2018;15(6). https://doi.org/10.3390/ijerph15061084.

    Article  Google Scholar 

  87. Audrain-McGovern J, Benowitz NL. Cigarette smoking, nicotine, and body weight. Clin Pharmacol Ther. 2011;90(1):164–8. https://doi.org/10.1038/clpt.2011.105.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  88. Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature. 2006;444(7121):875–80. https://doi.org/10.1038/nature05487.

    Article  CAS  PubMed  Google Scholar 

  89. Verhaegen A, Van Gaal L. Do E-cigarettes induce weight changes and increase cardiometabolic risk? A signal for the future. Obesity reviews : an official journal of the International Association for the Study of Obesity. 2017;18(10):1136–46. https://doi.org/10.1111/obr.12568.

    Article  CAS  Google Scholar 

  90. Yuan S, Xue HL, Yu HJ, Huang Y, Tang BW, Yang XH, et al. Cigarette smoking as a risk factor for type 2 diabetes in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Journal of public health (Oxford, England). 2018. https://doi.org/10.1093/pubmed/fdy106.

    Article  Google Scholar 

  91. Eliasson B, Attvall S, Taskinen MR, Smith U. Smoking cessation improves insulin sensitivity in healthy middle-aged men. Eur J Clin Investig. 1997;27(5):450–6.

    Article  CAS  Google Scholar 

  92. Centers for Disease C, Prevention, National Center for Chronic Disease P, Health P, Office on S, Health. Publications and Reports of the Surgeon General. How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. Atlanta (GA): Centers for Disease Control and Prevention (US); 2010.

  93. Ino T. Maternal smoking during pregnancy and offspring obesity: meta-analysis. Pediatrics international : official journal of the Japan Pediatric Society. 2010;52(1):94–9. https://doi.org/10.1111/j.1442-200X.2009.02883.x.

    Article  Google Scholar 

  94. Athyros VG, Katsiki N, Doumas M, Karagiannis A, Mikhailidis DP. Effect of tobacco smoking and smoking cessation on plasma lipoproteins and associated major cardiovascular risk factors: a narrative review. Curr Med Res Opin. 2013;29(10):1263–74. https://doi.org/10.1185/03007995.2013.827566.

    Article  PubMed  Google Scholar 

  95. El Golli N, Dkhili H, Dallagi Y, Rahali D, Lasram M, Bini-Dhouib I, et al. Comparison between electronic cigarette refill liquid and nicotine on metabolic parameters in rats. Life Sci. 2016;146:131–8. https://doi.org/10.1016/j.lfs.2015.12.049.

    Article  CAS  PubMed  Google Scholar 

  96. McGrath-Morrow SA, Hayashi M, Aherrera A, Lopez A, Malinina A, Collaco JM, et al. The effects of electronic cigarette emissions on systemic cotinine levels, weight and postnatal lung growth in neonatal mice. PloS one. 2015;10(2):e0118344. https://doi.org/10.1371/journal.pone.0118344.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  97. Hasan KM, Friedman TC, Shao X, Parveen M, Sims C, Lee DL, et al. E-cigarettes and Western diet: important metabolic risk factors for hepatic diseases. Md).: Hepatology (Baltimore; 2019. https://doi.org/10.1002/hep.30512.

    Book  Google Scholar 

  98. Russo C, Cibella F, Caponnetto P, Campagna D, Maglia M, Frazzetto E, et al. Evaluation of post cessation weight gain in a 1-year randomized smoking cessation trial of electronic cigarettes. Sci Rep. 2016;6:18763. https://doi.org/10.1038/srep18763.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  99. Russo C, Cibella F, Mondati E, Caponnetto P, Frazzetto E, Caruso M, et al. Lack of substantial post-cessation weight increase in electronic cigarettes users. International journal of environmental research and public health. 2018;15(4). https://doi.org/10.3390/ijerph15040581.

    Article  Google Scholar 

  100. Walele T, Bush J, Koch A, Savioz R, Martin C, O'Connell G. Evaluation of the safety profile of an electronic vapour product used for two years by smokers in a real-life setting. Regulatory toxicology and pharmacology : RTP. 2018;92:226–38. https://doi.org/10.1016/j.yrtph.2017.12.010.

    Article  CAS  PubMed  Google Scholar 

  101. Moheimani RS, Bhetraratana M, Peters KM, Yang BK, Yin F, Gornbein J, et al. Sympathomimetic effects of acute e-cigarette use: role of nicotine and non-nicotine constituents. Journal of the American Heart Association. 2017;6(9). https://doi.org/10.1161/jaha.117.006579.

  102. Centers for Disease Control and Prevention. The health consequences of smoking—50 years of progress. A Report of the Surgeon General. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion. Office on Smoking and Health. 2014. https://www.cdc.gov/tobacco/data_statistics/sgr/50th-anniversary/index.htm. Accessed 28 august 2019.

  103. Farber HJ, Nelson KE, Groner JA, Walley SC. Public policy to protect children from tobacco, nicotine, and tobacco smoke. Pediatrics. 2015;136(5):998–1007. https://doi.org/10.1542/peds.2015-3109.

    Article  PubMed  Google Scholar 

  104. Jenssen BP, Boykan R. Electronic cigarettes and youth in the United States: a call to action (at the Local, National and Global Levels). Children (Basel). 2019;6(2). https://doi.org/10.3390/children6020030.

    Article  Google Scholar 

  105. Center PHL. U.S. E-CIGARETTE REGULATIONS - 50 STATE REVIEW (2019). 2019. https://www.publichealthlawcenter.org/resources/us-e-cigarette-regulations-50-state-review. Accessed august 29 2019.

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology, Diabetology and Metabolism, Antwerp University Hospital, 2650, Edegem, Belgium

    Ann Verhaegen & Luc Van Gaal

Authors
  1. Ann Verhaegen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Luc Van Gaal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Luc Van Gaal.

Ethics declarations

Conflict of Interest

Prof Van Gaal and Dr Verhaegen declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the topical collection on Cardiovascular Risk Health Policy

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Verhaegen, A., Van Gaal, L. Vaping and Cardiovascular Health: the Case for Health Policy Action. Curr Cardiovasc Risk Rep 13, 37 (2019). https://doi.org/10.1007/s12170-019-0634-9

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s12170-019-0634-9

Keywords

Search

Navigation